Literature DB >> 19641264

Reversible contraception update: the importance of long-acting reversible contraception.

Renee E Mestad1, Jessica Kenerson, Jeffrey F Peipert.   

Abstract

The past several years have seen an expansion in contraception options. Emerging data support the use of long-acting reversible contraception (LARC) such as the intrauterine device and subdermal implant as the most effective methods of contraception with the highest continuation rates and very high levels of patient satisfaction. In addition, the appropriate target population for the use of the intrauterine device now includes nulliparous women and adolescents. When a patient considers initiating a new contraceptive method, it is important to consider the characteristics of each method, including the side effects, effectiveness, and patient acceptability. Additionally, medical comorbidities must also be evaluated prior to choosing a method. In this article, we provide a brief overview of available reversible contraceptive methods, with an emphasis on LARC.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19641264      PMCID: PMC3164772          DOI: 10.3810/pgm.2009.07.2025

Source DB:  PubMed          Journal:  Postgrad Med        ISSN: 0032-5481            Impact factor:   3.840


  12 in total

1.  ACOG practice bulletin. Clinical management guidelines for obstetrician-gynecologists. Number 59, January 2005. Intrauterine device.

Authors: 
Journal:  Obstet Gynecol       Date:  2005-01       Impact factor: 7.661

2.  ACOG practice bulletin. No. 73: Use of hormonal contraception in women with coexisting medical conditions.

Authors: 
Journal:  Obstet Gynecol       Date:  2006-06       Impact factor: 7.661

3.  The risk of pregnancy after tubal sterilization: findings from the U.S. Collaborative Review of Sterilization.

Authors:  H B Peterson; Z Xia; J M Hughes; L S Wilcox; L R Tylor; J Trussell
Journal:  Am J Obstet Gynecol       Date:  1996-04       Impact factor: 8.661

4.  Ovarian function after seven years' use of a levonorgestrel IUD.

Authors:  I Barbosa; S E Olsson; V Odlind; T Goncalves; E Coutinho
Journal:  Adv Contracept       Date:  1995-06

5.  The effect of past use of the injectable contraceptive depot medroxyprogesterone acetate on bone mineral density in normal post-menopausal women.

Authors:  B J Orr-Walker; M C Evans; R W Ames; J M Clearwater; T Cundy; I R Reid
Journal:  Clin Endocrinol (Oxf)       Date:  1998-11       Impact factor: 3.478

6.  Emergency contraception with Multiload Cu-375 SL IUD: a multicenter clinical trial.

Authors:  L Zhou; B Xiao
Journal:  Contraception       Date:  2001-08       Impact factor: 3.375

7.  Ultrasound demonstration of increased frequency of functional ovarian cysts in women using progestogen-only oral contraception.

Authors:  Y Tayob; J Adams; H S Jacobs; J Guillebaud
Journal:  Br J Obstet Gynaecol       Date:  1985-10

8.  Risk of nonfatal venous thromboembolism in women using a contraceptive transdermal patch and oral contraceptives containing norgestimate and 35 microg of ethinyl estradiol.

Authors:  Susan S Jick; James A Kaye; Stefan Russmann; Hershel Jick
Journal:  Contraception       Date:  2006-01-26       Impact factor: 3.375

9.  A prospective study of the incidence of deep-vein thrombosis within a defined urban population.

Authors:  M Nordström; B Lindblad; D Bergqvist; T Kjellström
Journal:  J Intern Med       Date:  1992-08       Impact factor: 8.989

10.  Changes in bone density with lactation.

Authors:  M Sowers; G Corton; B Shapiro; M L Jannausch; M Crutchfield; M L Smith; J F Randolph; B Hollis
Journal:  JAMA       Date:  1993 Jun 23-30       Impact factor: 56.272

View more
  1 in total

1.  Preventing Unintended Pregnancy Among Young Sexually Active Women: Recognizing the Role of Violence, Self-Esteem, and Depressive Symptoms on Use of Contraception.

Authors:  Deborah B Nelson; Huaqing Zhao; Rachel Corrado; Dimitrios M Mastrogiannnis; Stephen J Lepore
Journal:  J Womens Health (Larchmt)       Date:  2017-01-03       Impact factor: 2.681

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.